Form 8-K BIOGEN INC. For: Jan 29
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Biogen (BIIB) PT Lowered to $337 at RBC Capital
January 30, 2019 6:25 AM ESTRBC Capital analyst Brian Abrahams lowered the price target on Biogen (NASDAQ: BIIB) to $337.00 (from $342.00) while maintaining a Sector Perform rating.
... MoreBiogen (BIIB) PT Raised to $380 at Oppenheimer
January 29, 2019 5:29 PM ESTOppenheimer analyst Jay Olson raised the price target on Biogen (NASDAQ: BIIB) to $380.00 (from $372.00) while maintaining a Outperform rating.
Olson noted an 'impressive' Q4 performance which featured a business update that perplexed investors with plans for an intriguing Alzheimer's prevention study.
... More